PMID- 28429906
OWN - NLM
STAT- MEDLINE
DCOM- 20170713
LR  - 20181023
IS  - 0964-7058 (Print)
IS  - 0964-7058 (Linking)
VI  - 26
IP  - 3
DP  - 2017 May
TI  - Eating glutinous brown rice for one day improves glycemic control in Japanese 
      patients with type 2 diabetes assessed by continuous glucose monitoring.
PG  - 421-426
LID - 10.6133/apjcn.042016.07 [doi]
AB  - BACKGROUND AND OBJECTIVES: We investigated whether intake of non-glutinous brown 
      rice (BR) or glutinous brown rice (GBR) for 1 day had an influence on the daily 
      glucose profile measured by continuous glucose monitoring (CGM) when compared 
      with intake of non-glutinous white rice (WR). METHODS AND STUDY DESIGN: A total 
      of 37 inpatients with type 2 diabetes mellitus (T2DM) were recruited for a 3-day 
      randomized triple cross-over trial in which they ate WR, BR, or GBR for 1 day 
      each. One of the three types of rice was eaten at breakfast, lunch, and dinner on 
      the first day, before switching to the other types on the second and third days. 
      Each meal had the same energy content and the same side dishes. The main outcome 
      measures were the blood glucose profile determined by continuous glucose 
      monitoring (CGM) and the profile of serum C-peptide (CPR) for 3 hours after 
      breakfast. A self-administered questionnaire was used to assess the palatability 
      of each type of rice. RESULTS: According to the CGM data, the mean 24-hour 
      glucose concentration was lowest with GBR (p<0.01). Serum Cpeptide showed no 
      significant differences among the three diets. Regarding palatability, BR was 
      assigned significantly lower scores than WR and GBR (p<0.05), while there was no 
      difference between WR and GBR. CONCLUSIONS: GBR intake suppressed the whole-day 
      glucose profile of patients with T2DM, mainly by reducing postprandial glucose 
      excursion, and GBR was preferred over BR with respect to palatability. GBR may be 
      worth adding to the diet of patients with T2DM.
FAU - Terashima, Yuko
AU  - Terashima Y
AD  - Division of Metabolism and Endocrinology, Department of Internal Medicine, St. 
      Marianna University School of Medicine, Kanagawa, Japan.
FAU - Nagai, Yoshio
AU  - Nagai Y
AD  - Division of Metabolism and Endocrinology, Department of Internal Medicine, St. 
      Marianna University School of Medicine, Kanagawa, Japan. Email: 
      ynagai@marianna-u.ac.jp.
FAU - Kato, Hiroyuki
AU  - Kato H
AD  - Division of Metabolism and Endocrinology, Department of Internal Medicine, St. 
      Marianna University School of Medicine, Kanagawa, Japan.
FAU - Ohta, Akio
AU  - Ohta A
AD  - Division of Metabolism and Endocrinology, Department of Internal Medicine, St. 
      Marianna University School of Medicine, Kanagawa, Japan.
FAU - Tanaka, Yasushi
AU  - Tanaka Y
AD  - Division of Metabolism and Endocrinology, Department of Internal Medicine, St. 
      Marianna University School of Medicine, Kanagawa, Japan.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - China
TA  - Asia Pac J Clin Nutr
JT  - Asia Pacific journal of clinical nutrition
JID - 9440304
RN  - 0 (Blood Glucose)
RN  - 0 (C-Peptide)
RN  - 0 (Hypoglycemic Agents)
SB  - IM
MH  - Aged
MH  - Blood Glucose/*analysis
MH  - Body Mass Index
MH  - C-Peptide/blood
MH  - Cross-Over Studies
MH  - Diabetes Mellitus, Type 2/blood/*diet therapy
MH  - *Diet
MH  - Female
MH  - Humans
MH  - Hyperglycemia/diet therapy
MH  - Hypoglycemic Agents
MH  - Male
MH  - Middle Aged
MH  - Monitoring, Physiologic
MH  - *Oryza
MH  - Surveys and Questionnaires
EDAT- 2017/04/22 06:00
MHDA- 2017/07/14 06:00
CRDT- 2017/04/22 06:00
PHST- 2017/04/22 06:00 [entrez]
PHST- 2017/04/22 06:00 [pubmed]
PHST- 2017/07/14 06:00 [medline]
AID - 10.6133/apjcn.042016.07 [doi]
PST - ppublish
SO  - Asia Pac J Clin Nutr. 2017 May;26(3):421-426. doi: 10.6133/apjcn.042016.07.